Search by Drug Name or NDC
NDC 65219-0371-10 STIMUFEND 6 mg/.6mL Details
STIMUFEND 6 mg/.6mL
STIMUFEND is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is PEGFILGRASTIM.
Product Information
| NDC | 65219-0371 |
|---|---|
| Product ID | 65219-371_90fa8a88-1bd6-49cf-a482-ccbc0d315b3d |
| Associated GPIs | |
| GCN Sequence Number | 083790 |
| GCN Sequence Number Description | pegfilgrastim-fpgk SYRINGE 6 MG/0.6ML SUBCUT |
| HIC3 | N1C |
| HIC3 Description | LEUKOCYTE (WBC) STIMULANTS |
| GCN | 52848 |
| HICL Sequence Number | 048269 |
| HICL Sequence Number Description | PEGFILGRASTIM-FPGK |
| Brand/Generic | Brand |
| Proprietary Name | STIMUFEND |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | pegflilgrastim-fpgk |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 6 |
| Active Ingredient Units | mg/.6mL |
| Substance Name | PEGFILGRASTIM |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA761173 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65219-0371-10 (65219037110)
| NDC Package Code | 65219-371-10 |
|---|---|
| Billing NDC | 65219037110 |
| Package | 1 BLISTER PACK in 1 CARTON (65219-371-10) / 1 SYRINGE in 1 BLISTER PACK / .6 mL in 1 SYRINGE |
| Marketing Start Date | 2022-10-06 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |